Henry Du
Patrimonio netto: - $ in data 30/06/2026
Patrimonio netto: - $ in data 30/06/2026
Henry H.
Du is currently Director at Emmaus Life Sciences, Inc. since 2026 and Chief Financial Officer, VP-Finance & Accounting at Alpha Cognition, Inc. since 2024.
Formerly, Mr. Du was Senior Vice President-Accounting & Administration at Amplify Surgical, Inc. from 2022 to 2024 and VP-Finance & Senior Corporate Controller at Huyabio International LLC from 2021 to 2022.
Education includes undergraduate studies at Claremont McKenna College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ALPHA COGNITION INC -.--% | 24/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALPHA COGNITION INC. | Direttore Finanziario/CFO | 21/10/2024 |
| EMMAUS LIFE SCIENCES, INC. | Direttore/Membro del Consiglio | 16/04/2026 |
| Società | Posizione | Fine |
|---|---|---|
Amplify Surgical, Inc.
Amplify Surgical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets spinal implant devices | Direttore Amministrativo | 01/10/2024 |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Direttore Finanziario/CFO | 01/11/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Claremont McKenna College
Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amplify Surgical, Inc.
Amplify Surgical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets spinal implant devices | Health Technology |
Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale